These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4498548)
21. [Mode of action of antiarrhythmic drugs (author's transl)]. Sano T Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686 [No Abstract] [Full Text] [Related]
22. [Effects of xylocaine on myocardial conduction. Electrocardiographic and clinical experience]. Pellegrino L Minerva Cardioangiol; 1973 Jan; 21(1):51-9. PubMed ID: 4572003 [No Abstract] [Full Text] [Related]
23. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias. Mattea J; Mattea E Am J Nurs; 1976 Sep; 76(9):1429-31. PubMed ID: 1048862 [No Abstract] [Full Text] [Related]
24. Current understanding of lidocaine as an antiarrhythmic agent: a review. Anderson JL Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230 [TBL] [Abstract][Full Text] [Related]
25. [Clinical experience with lidocaine in the treatment of cardiac arrhythmias]. Pellegrino L; Casari A; Salerno J Clin Ter; 1971 Nov; 59(3):213-28. PubMed ID: 5160468 [No Abstract] [Full Text] [Related]
26. Pharmacologic and clinical control of antiarrhythmic drugs. Bigger JT Am J Med; 1975 Apr; 58(4):479-88. PubMed ID: 1092163 [TBL] [Abstract][Full Text] [Related]
27. Treatment of cardiac arrhythmias in dogs with gastric distention-volvulus. Muir WW; Bonagura JD J Am Vet Med Assoc; 1984 Jun; 184(11):1366-71. PubMed ID: 6735858 [TBL] [Abstract][Full Text] [Related]
29. Influence of plasma drug level and the presence of conduction disease on the electrophysiologic effects of procainamide. Wyse DG; McAnulty JH; Rahimtoola SH Am J Cardiol; 1979 Mar; 43(3):619-26. PubMed ID: 420112 [No Abstract] [Full Text] [Related]
30. Drugs and the atrioventricular conducting system. Caracta AR; Damato AN Cardiovasc Clin; 1977; 8(3):267-84. PubMed ID: 338150 [No Abstract] [Full Text] [Related]
32. [Effects of several anti-arrhythmia agents on excitability and conduction depressed by digitalis agents]. Márquez M; Kabela E Arch Inst Cardiol Mex; 1984; 54(6):535-44. PubMed ID: 6241458 [TBL] [Abstract][Full Text] [Related]
33. [Antiarrhythmic drugs]. Ben Naceur M; Houissa D Tunis Med; 1972; 50(4):305-13. PubMed ID: 4662464 [No Abstract] [Full Text] [Related]
34. [Revival of an old drug]. Lakartidningen; 1969 Jan; 66(3):210-1. PubMed ID: 4181165 [No Abstract] [Full Text] [Related]
35. [Lidocaine and conduction disorders (3 illustrative cases)]. Dimitriu CG; Karassi A; Gavrilă F Med Interna (Bucur); 1972 Jan; 24(1):9-13. PubMed ID: 5021768 [No Abstract] [Full Text] [Related]
36. Rational use of antiarrhythmic drugs alone and in combination. Bigger JT; Giardina EG Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454 [No Abstract] [Full Text] [Related]
37. Experimental evaluation of antiarrhythmic drugs in the guinea pig. Giudicelli JF; Witchitz S; Larno S; Boissier JR Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987 [No Abstract] [Full Text] [Related]
38. The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium. Levitt B; Borer JS; Sarapa A Cardiovasc Nurs; 1974; 10(6):27-31. PubMed ID: 4498549 [No Abstract] [Full Text] [Related]